AT478955T
Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
Abstract
An expression cassette comprising: (a) a polynucleotide comprising at least 480 contiguous nucleotides of SEQ ID NO: 132; or (b) a polynucleotide having more than 98% sequence identity with (a).
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
143 members in 13 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 61031300 | United States of America | A | |
| 0121241 | United States of America | W |
Members143
| Document | Office | Kind | |
|---|---|---|---|
| CA2358385A1 | Canada | A1 | |
| CA2358915A1 | Canada | A1 | |
| CA2360347A1 | Canada | A1 | |
| WO0039302A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0039303A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0039304A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2221600A | Australia | A | |
| AU2487300A | Australia | A | |
| AU2596600A | Australia | A | |
| WO0039303A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0039304A9 | World Intellectual Property Organization (WIPO) | A9 | |
| WO0039302A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0039304A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1141313A2 | European Patent Office (EPO) | A2 | |
| EP1141314A2 | European Patent Office (EPO) | A2 | |
| EP1141315A2 | European Patent Office (EPO) | A2 | |
| CA2414374A1 | Canada | A1 | |
| WO0204493A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU7317901A | Australia | A | |
| ZA200105590B | South Africa | B | |
| ZA200105589B | South Africa | B | |
| JP2002533124A | Japan | A | |
| JP2002533125A | Japan | A | |
| US2002146683A1 | United States of America | A1 | |
| CA2452015A1 | Canada | A1 | |
| CA2452119A1 | Canada | A1 | |
| CA2634992A1 | Canada | A1 | |
| CA2785699A1 | Canada | A1 | |
| WO03004620A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO03004657A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2002320314A1 | Australia | A1 | |
| CA2458995A1 | Canada | A1 | |
| WO03020876A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002316578A1 | Australia | A1 | |
| CA2453228A1 | Canada | A1 | |
| WO03027022A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002356505A1 | Australia | A1 | |
| WO0204493A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2003143248A1 | United States of America | A1 | |
| US6602705B1 | United States of America | B1 | |
| WO03027022A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JP2003523721A | Japan | A | |
| EP1339738A2 | European Patent Office (EPO) | A2 | |
| US2003170614A1 | United States of America | A1 | |
| US2003194800A1 | United States of America | A1 | |
| US2003198621A1 | United States of America | A1 | |
| US2003223961A1 | United States of America | A1 | |
| US2003223964A1 | United States of America | A1 | |
| WO03020876A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03004620A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JP2004502445A | Japan | A | |
| US6689879B2 | United States of America | B2 | |
| EP1409694A1 | European Patent Office (EPO) | A1 | |
| EP1411770A2 | European Patent Office (EPO) | A2 | |
| EP1427806A2 | European Patent Office (EPO) | A2 | |
| EP1433851A2 | European Patent Office (EPO) | A2 | |
| ZA200300839B | South Africa | B | |
| EP1433851A3 | European Patent Office (EPO) | A3 | |
| JP2004537303A | Japan | A | |
| ZA200403143B | South Africa | B | |
| US6893567B1 | United States of America | B1 | |
| EP1535995A1 | European Patent Office (EPO) | A1 | |
| JP2005521380A | Japan | A | |
| ZA200400802B | South Africa | B | |
| JP2005523679A | Japan | A | |
| US2005214256A1 | United States of America | A1 | |
| ZA200402513B | South Africa | B | |
| EP1409694A4 | European Patent Office (EPO) | A4 | |
| ZA200400793B | South Africa | B | |
| US2006057115A1 | United States of America | A1 | |
| EP1427806A4 | European Patent Office (EPO) | A4 | |
| EP1411770A4 | European Patent Office (EPO) | A4 | |
| US7211659B2 | United States of America | B2 | |
| US7282364B2 | United States of America | B2 | |
| EP1141315B1 | European Patent Office (EPO) | B1 | |
| AT384795T | Austria | T | |
| DE69938062D1 | Germany | D1 | |
| US7348177B2 | United States of America | B2 | |
| US2008089908A1 | United States of America | A1 | |
| US2008095833A1 | United States of America | A1 | |
| PT1141315E | Portugal | E | |
| ES2299276T3 | Spain | T3 | |
| DK1141315T3 | Denmark | T3 | |
| EP1980617A1 | European Patent Office (EPO) | A1 | |
| US2008261271A1 | United States of America | A1 | |
| US2009004733A1 | United States of America | A1 | |
| DE69938062T2 | Germany | T2 | |
| US2009047339A1 | United States of America | A1 | |
| JP2009039116A | Japan | A | |
| JP2009082136A | Japan | A | |
| JP4302513B2 | Japan | B2 | |
| JP2009254383A | Japan | A | |
| US7618642B2 | United States of America | B2 | |
| US2009304740A1 | United States of America | A1 | |
| US7662916B2 | United States of America | B2 | |
| US2010092502A1 | United States of America | A1 | |
| US7718401B2 | United States of America | B2 | |
| CA2358915C | Canada | C | |
| EP2206785A1 | European Patent Office (EPO) | A1 | |
| EP1339738B1 | European Patent Office (EPO) | B1 |
Showing 100 of 143
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 1952426
Titles2
- German
- FÜR ANTIGENE POLYPEPTIDE DES HIV TYPE C KODIERENDE NUKLEINSÄUREN, ENTSPRECHENDE POLYPEPTIDE UND VERWENDUNGEN DAVON
- English
- NUCLEIC ACIDS CODING FOR ANTIGENIC TYPE C POLYPEPTIDES, CORRESPONDING POLYPEPTIDES AND USES THEREOF
Classification
- CPC, 9
- C07K14/005
- A61K39/00
- A61K2039/53
- A61P31/12
- C12N2740/16122
- A61P31/18
- C12N2740/16222
- A61P37/04
- C12N2740/16322
- IPC, 14
- A61K35 76
- A61K38 00
- A61K39 00
- A61K39 21
- A61K48 00
- A61P31 12
- A61P31 18
- C07K14 16
- C12N1 15
- C12N1 19
- C12N1 21
- C12N15 09
- C12N15 48
- C12N5 10